AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.030
+0.190 (6.69%)
At close: Apr 28, 2026, 4:00 PM EDT
2.931
-0.099 (-3.27%)
After-hours: Apr 28, 2026, 7:33 PM EDT
AC Immune Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AC Immune stock have an average target of 10, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 230.03% from the current stock price of 3.03.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 16, 2026.
Analyst Ratings
The average analyst rating for AC Immune stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +164.03% | Mar 16, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +164.03% | Nov 4, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +164.03% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +296.04% | May 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +428.05% | Apr 3, 2025 |
Financial Forecast
Revenue This Year
28.83M
from 3.57M
Increased by 706.75%
Revenue Next Year
121.39M
from 28.83M
Increased by 321.13%
EPS This Year
-0.56
from -0.70
EPS Next Year
0.51
from -0.56
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 94.5M | 191.6M | |||
| Avg | 28.8M | 121.4M | |||
| Low | 3.2M | 79.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2,544.8% | 564.8% | |||
| Avg | 706.7% | 321.1% | |||
| Low | -11.1% | 174.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.37 | 1.37 | |||
| Avg | -0.56 | 0.51 | |||
| Low | -0.67 | 0.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.